Novartis has had the efficacy of its blood pressure treatment Rasilez supported by new data from a year-long study conducted by the 3A Registry. The registry, which represents the largest […]
Novartis has had the efficacy of its blood pressure treatment Rasilez supported by new data from a year-long study conducted by the 3A Registry. The registry, which represents the largest […]